P
Peter Valent
H指数:131
被引数:7.2万
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatment
CDK6失活对抗CALR突变诱导的MPN演化并使MPN干细胞对干扰素-α治疗敏感
HemaSphere
IF14.6
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis
靶向CD117的CAR T细胞在先进系统性肥大细胞增多症的临床前模型中有效清除肥大细胞
Leukemia
IF13.4
Triterpenoid Exposure and HO-1 Blockade Sensitize Neoplastic Mast Cells Against Midostaurin and Avapritinib
三萜暴露和HO-1阻断使肿瘤性肥大细胞对米多司他汀和阿瓦普利替尼更敏感
Cells
IF5.2
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in new era: A CIBMTR study
异基因造血细胞移植在新时代晚期系统性肥大细胞增生症中的应用:一项CIBMTR研究
Bone marrow mastocytosis associated with primary cutaneous follicle center lymphoma: an unusual case report
骨髓肥大细胞增多症与原发性皮肤滤泡中心淋巴瘤相关:一例罕见的病例报告
Annals of Hematology
IF2.4
A COMPARISON OF PROGNOSTIC VARIABLES AND CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED AND 4738 WITH PRIMARY MDS INCLUDING THE INFLUENCE OF TREATMENT IN MDS-PHASE
比较治疗相关和原发性MDS的1590例与4738例患者预后变量和细胞遗传学异常的比较,包括MDS阶段治疗的影响
LEUKEMIA RESEARCH
IF2.2
Latent structure and measurement invariance of the post-traumatic stress Scale-10 in cancer patients
创伤后应激量表-10在癌症患者中的潜在结构和测量不变性
ACTA PSYCHOLOGICA
IF2.7
ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implications
ADH5/ALDH2脱氢酶和DNA聚合酶theta保护正常和恶性造血细胞免受甲醛挑战:治疗意义
Leukemia
IF13.4
Evolution of Mast Cell Research Associated with the Laboratory of Allergic Diseases: 1985-2022 Presented at 2023 NIAID Symposium
与过敏性疾病实验室相关的肥大细胞研究进展:1985-2022(2023年NIAID研讨会报告)
The enhanced integration of proven techniques to quantify the uncertainty of forecasting extreme flood events based on numerical weather prediction models
基于数值天气预报模型的,对极端洪水事件预测不确定性的量化中,经过验证技术的增强集成
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12
NUP98::KDM5A融合癌蛋白通过转录和表观遗传重编程直接激活CDK12
Nature Communications
IF15.7
Comparing functional and genomic-based precision medicine in blood cancer patients
比较基于功能与基因组学的血液肿瘤患者精准医学
HEMASPHERE
IF14.6

